Here's the live share price of Orchid Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Orchid Pharma has gained 108.80% CAGR. Over the past year, the corresponding return has been -50.16%.
Orchid Pharma’s current P/E of 42.52x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Orchid Pharma | 0.07 | -5.53 | 1.77 | -11.28 | -50.16 | 29.60 | 108.80 |
Sun Pharmaceutical Industries | 1.67 | -0.74 | -1.73 | -5.03 | -13.17 | 22.82 | 25.92 |
Divi's Laboratories | 0.43 | -1.79 | -7.35 | 6.82 | 11.03 | 18.72 | 13.53 |
Cipla | -0.28 | -0.33 | 3.71 | 4.44 | -6.69 | 14.64 | 15.70 |
Torrent Pharmaceuticals | -1.10 | -2.72 | 9.28 | 16.13 | 2.96 | 33.93 | 20.15 |
Dr. Reddy's Laboratories | 0.52 | 3.73 | -0.61 | 13.95 | -1.15 | 16.94 | 6.31 |
Mankind Pharma | -1.64 | 3.88 | 9.08 | 18.13 | 4.58 | 21.69 | 12.50 |
Zydus Lifesciences | -0.57 | 4.75 | 7.77 | 15.69 | -6.93 | 42.16 | 21.26 |
Lupin | 2.60 | 3.02 | 4.40 | 1.91 | -10.64 | 46.79 | 14.35 |
Abbott India | -0.85 | -4.90 | -2.43 | 2.84 | 7.47 | 21.30 | 13.54 |
Alkem Laboratories | 2.66 | 2.12 | 13.49 | 13.40 | -12.19 | 18.95 | 13.98 |
Aurobindo Pharma | 4.16 | 0.37 | -1.39 | -1.69 | -29.51 | 28.16 | 6.17 |
Glenmark Pharmaceuticals | -4.41 | 3.19 | 23.20 | 42.38 | 18.91 | 76.49 | 32.85 |
Anthem Biosciences | 5.89 | 7.84 | 18.23 | 18.23 | 18.23 | 5.74 | 3.41 |
Laurus Labs | -0.51 | 3.09 | 35.04 | 53.43 | 77.96 | 20.69 | 25.98 |
Biocon | -2.53 | -2.59 | 0.62 | 6.24 | -5.53 | 6.94 | -4.31 |
GlaxoSmithKline Pharmaceuticals | -3.46 | -1.94 | -15.89 | 1.60 | -2.30 | 24.69 | 9.19 |
Cohance Lifesciences | -2.30 | 7.56 | -2.57 | -14.86 | -16.33 | 28.11 | 20.30 |
Ipca Laboratories | -0.07 | -5.18 | -3.23 | -0.19 | -9.85 | 15.26 | 4.10 |
Gland Pharma | 4.39 | 0.78 | 13.75 | 27.92 | 7.57 | -3.99 | 1.77 |
Over the last one year, Orchid Pharma has declined 50.16% compared to peers like Sun Pharmaceutical Industries (-13.17%), Divi's Laboratories (11.03%), Cipla (-6.69%). From a 5 year perspective, Orchid Pharma has outperformed peers relative to Sun Pharmaceutical Industries (25.92%) and Divi's Laboratories (13.53%).
Day | SMA | EMA |
---|---|---|
5 | 710.84 | 710.8 |
10 | 717.5 | 716.95 |
20 | 738.9 | 727.57 |
50 | 739.56 | 738.21 |
100 | 739.17 | 785.75 |
200 | 1,015.01 | 900.95 |
In the latest quarter, Orchid Pharma remained same as its previous close in promoter holding, while DII stake decreased to 19.43%, FII holding fell to 1.39%, and public shareholding moved up to 9.34% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Quant Small Cap Fund | 34,65,947 | 0.88 | 254.42 |
Invesco India Contra Fund | 10,44,216 | 0.4 | 76.65 |
UTI Value Fund | 6,80,645 | 0.52 | 49.96 |
Nippon India Pharma Fund | 4,92,727 | 0.43 | 36.17 |
Invesco India Smallcap Fund | 4,55,183 | 0.43 | 33.41 |
UTI Small Cap Fund | 2,83,362 | 0.44 | 20.8 |
Bandhan Small Cap Fund | 2,54,952 | 0.13 | 18.71 |
Invesco India Multicap Fund | 2,05,673 | 0.37 | 15.1 |
Invesco India ELSS Tax Saver Fund | 1,53,202 | 0.4 | 11.25 |
Kotak Multicap Fund | 1,14,308 | 0.04 | 8.39 |
Date Time | Announcement |
---|---|
Sep 11, 2025, 12:31 AM IST | Orchid Pharma - Corrigendum To Notice Of 32Nd Annual General Meeting Of Orchid Pharma Limited ('The Company') For The F.Y. 20 |
Sep 11, 2025, 12:01 AM IST | Orchid Pharma - CORRIGENDUM TO NOTICE OF 32ND ANNUAL GENERAL MEETING |
Aug 30, 2025, 12:25 AM IST | Orchid Pharma - Intimation Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited ( Amalgamating Company ) Wit |
Aug 27, 2025, 5:49 AM IST | Orchid Pharma - Business Responsibility and Sustainability Reporting (BRSR) |
Aug 27, 2025, 3:35 AM IST | Orchid Pharma - Reg. 34 (1) Annual Report. |
Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 921.93 Cr. and Equity Capital is Rs. 50.72 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Orchid Pharma is ₹714.45 as on Sep 17, 2025.
The Orchid Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Orchid Pharma is ₹3,623.63 Cr as on Sep 17, 2025.
Today’s highest and lowest price of Orchid Pharma are ₹724.00 and ₹705.00.
The 52-week high/low is the highest and lowest price at which Orchid Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Orchid Pharma is ₹1,998.00 and 52-week low of Orchid Pharma is ₹603.80 as on Sep 17, 2025.
The Orchid Pharma has shown returns of 0.78% over the past day, -5.53% for the past month, 1.77% over 3 months, -50.16% over 1 year, 29.6% across 3 years, and 108.8% over 5 years.
P/E ratio of and PB ratio of Orchid Pharma are 42.52 and 2.96 on Sep 17, 2025. While the company gives a dividend yield of 0.00 per annum.